Single Payer: What It Is and Why It Matters

The United States spends more on health care per capita than any other high-income nation — reaching $13,493 per person in 2022 according to the Centers for Medicare & Medicaid Services (CMS) National Health Expenditure data — yet coverage gaps persist for tens of millions of people. Single-payer health financing represents one of the most debated structural responses to this gap, proposing to replace fragmented payment sources with a single public fund. This page covers the mechanics, boundaries, regulatory context, and common misconceptions surrounding single-payer systems, drawing on federal legislative proposals, international models, and U.S. policy analysis. Readers can also explore frequently asked questions for targeted answers on eligibility, financing, and transition logistics.

• Core moving parts
• Where the public gets confused
• Boundaries and exclusions
• The regulatory footprint
• What qualifies and what does not
• Primary applications and contexts
• How this connects to the broader framework
• Scope and definition

Core moving parts

A single-payer system is a health care financing arrangement in which one public entity — typically a national or state government agency — collects all health care revenues and pays all covered medical bills, while delivery of care remains predominantly in private or publicly owned hands. The phrase "single payer" refers strictly to the payment mechanism, not to who owns the hospitals, employs the physicians, or manufactures the drugs.

The structural mechanics involve four interdependent components:

1. Revenue collection — A single public fund pools contributions, typically through payroll taxes, income taxes, or dedicated levies. In the most-cited U.S. federal proposal, the Medicare for All Act (H.R. 3421 and companion Senate bills), financing relies on a combination of employer payroll taxes, wealth taxes, and capital gains provisions.
2. Benefit specification — The administering body defines a universal benefit package covering a defined set of services. Under proposals modeled on the Physicians for a National Health Program (PNHP) framework, that package typically includes hospital care, physician services, mental health, dental, vision, prescription drugs, and long-term care.
3. Provider payment — The single fund negotiates or sets prices for services, drugs, and devices. This monopsony-like purchasing power is the primary mechanism by which single-payer advocates argue costs would fall.
4. Claims adjudication — All billing flows through one administrative pathway rather than through the 900-plus private insurance companies currently operating in U.S. markets (per NAIC's Insurance Department Resources Report).

The interaction of these four components produces the system's defining property: administrative simplification. A 2019 analysis published in The BMJ estimated that U.S. administrative costs consumed approximately 34.2% of total health care expenditures, compared to 12.4% in Canada's single-payer system — a comparison frequently cited in legislative testimony.

Where the public gets confused

Three persistent confusions distort public understanding of single-payer proposals.

Confusion 1: Single payer equals socialized medicine. Socialized medicine means government ownership of facilities and employment of providers — the model used by the United Kingdom's National Health Service. Single payer does not require government ownership of hospitals or employment of physicians. Canada operates a single-payer system in which most hospitals are private nonprofits and most physicians are private practitioners billing a public insurer.

Confusion 2: Single payer and universal coverage are the same thing. Universal coverage is a goal — ensuring all residents have access to covered health services. Single payer is one financing mechanism for reaching that goal. Germany, Switzerland, and the Netherlands achieve near-universal coverage through multi-payer regulated insurance markets, not single-payer systems.

Confusion 3: Medicare is already single payer. Traditional Medicare is a public insurer for adults 65 and older plus qualifying disabled individuals — covering approximately 65 million beneficiaries as of CMS enrollment data. Medicare Advantage, which approximately 51% of Medicare beneficiaries had enrolled in by 2023 (KFF Medicare Advantage 2023 Spotlight), routes those beneficiaries through private insurers. Neither program covers the full population, so neither constitutes single payer in the technical sense.

Boundaries and exclusions

Single-payer architecture has firm definitional limits. The following are outside the single-payer definition regardless of how they are described in political discourse:

• Public option programs — A public insurance plan competing alongside private insurers in a market. Multiple payers remain.
• Medicaid expansion — Extends eligibility within an existing means-tested program; does not eliminate private insurance markets.
• All-payer rate setting — Requires all insurers to pay identical prices to providers but retains multiple payers. Maryland operates an all-payer hospital rate-setting system through the Health Services Cost Review Commission (HSCRC) — distinct from single payer.
• Employer self-insurance — ERISA-governed self-insured employer plans remain a private financing mechanism regardless of employer size.

What qualifies as single payer must satisfy two structural criteria: (1) a single fund holds and disburses substantially all health expenditures within the covered jurisdiction, and (2) private insurance for covered services is either prohibited or rendered redundant by the comprehensiveness of the public benefit.

The regulatory footprint

Any transition to a single-payer system in the U.S. context would engage at minimum the following federal statutory frameworks:

ERISA preemption represents the single largest structural barrier to state-level single-payer implementation. Because ERISA preempts state laws that "relate to" employee benefit plans, a state cannot compel self-insured employers — which cover roughly 65% of privately insured workers per KFF's 2023 Employer Health Benefits Survey — to contribute to a state single-payer fund without a federal ERISA waiver or statutory amendment.

Vermont's Act 48, passed in 2011, targeted a state-level single-payer system and was abandoned by 2014 in part because ERISA preemption left roughly 20% of the state's insured workforce outside the fund's reach — an insufficiency that made the financing model unworkable.

What qualifies and what does not

The following checklist identifies the structural features a financing arrangement must exhibit to qualify as single payer under the standard policy-science definition (as used by PNHP and in academic health policy literature):

• [ ] A single public or quasi-public entity collects revenues for health services
• [ ] That entity pays all covered-service claims within the jurisdiction
• [ ] Covered benefits are defined by statute or regulation, not by insurer product design
• [ ] Private insurance for the same covered services is prohibited or rendered actuarially nonviable by the comprehensiveness of the public benefit
• [ ] Provider participation is open to any licensed provider meeting quality standards, not restricted to a network
• [ ] Patients bear no premium at point of enrollment (cost-sharing at point of service may or may not exist depending on design)

Arrangements satisfying 4 of 6 criteria may be described as "near-single-payer" or "quasi-single-payer" in comparative health systems literature but do not meet the strict definition.

Primary applications and contexts

Single-payer financing operates at scale in Canada (provincially administered under the Canada Health Act of 1984), Taiwan (National Health Insurance, established 1995), South Korea (National Health Insurance Service), and several other jurisdictions. Each implementation differs in benefit scope, provider payment methodology, and cost-sharing design.

In the U.S., single-payer proposals appear in three primary contexts:

1. Federal legislation — The Medicare for All Act, versions of which have been introduced in multiple Congresses. The Senate companion introduced by Sen. Bernie Sanders in 2022 proposed a 4-year transition period and a benefit package explicitly broader than traditional Medicare, including dental, vision, and hearing.
2. State experimentation — Beyond Vermont, California's AB 1400 (2022) proposed a CalCare program before failing to advance to a floor vote. Colorado and New York have seen recurring single-payer legislation.
3. Academic and actuarial modeling — The Political Economy Research Institute (PERI) at UMass Amherst and the Rand Corporation have published competing cost models projecting different outcomes depending on administrative savings assumptions, provider payment benchmarks, and drug pricing provisions.

How this connects to the broader framework

Single-payer debate does not exist in isolation from adjacent health financing policy. It intersects with pharmaceutical pricing reform, hospital consolidation policy, workforce supply constraints, and long-term care financing — each of which represents a separate regulatory and legislative domain. The broader industry context for these intersecting topics is maintained through the Authority Network America framework, which coordinates reference-grade coverage across health financing, insurance markets, and public policy verticals.

Understanding single payer requires fluency in how private insurance markets are structured, how Medicaid and Medicare payment systems work, and how tax law shapes employer-sponsored coverage. The content on this site covers those intersections — from financing mechanics to navigational guidance for individuals seeking to understand their options within the current system.

Scope and definition

For precision in policy analysis, the following reference definitions are used consistently across this site:

The definitional boundary between single payer and related concepts matters because conflation distorts both cost projections and political feasibility assessments. Policy analyses that treat a public option or Medicaid buy-in as equivalent to single payer will produce fundamentally different administrative savings estimates — the primary source of projected cost offsets in single-payer financing models — because those alternatives preserve the multi-insurer administrative infrastructure that drives the 34.2% administrative cost share identified in comparative studies.

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)